Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$45.60 USD
-0.55 (-1.19%)
Updated Sep 18, 2025 04:00 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bristol Myers Squibb Company has a market cap of $92.82B, which represents its share price of $45.60 multiplied by its outstanding shares number of 2.04B. As a large-cap company, BMY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BMY 45.60 -0.55(-1.19%)
Will BMY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMY
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
BMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Stock Reports for Exxon Mobil, AMD & Caterpillar
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?
Other News for BMY
Peel Hunt Keeps Their Buy Rating on Bloomsbury Publishing (BMY)
Dividend Harvesting Portfolio Week 237: $23,700 Allocated, $2,573.68 In Projected Dividends
Is BMY compressing before expansion? Bollinger Band Squeeze shows up after sliding 0.41%
Bloomsbury Publishing Appoints New CFO to Drive AI and Digital Growth
J&J studies find icotrokinra more effective than deucravacitinib for psoriasis